Jin Medical International Ltd. (ZJYL): Market Cap to Revenue

Symbol and logo of brand Jin Medical International Ltd (ZJYL)

The P/S time series allows for a valuation of Jin Medical International (ZJYL), whose revenues are based on the global export of rehabilitation equipment. Human capital is provided by a staff of specialized engineers, while business maturity is confirmed by the integration of digital technologies into wheelchairs. The value of 29.10 is a current metric that, within this chart, helps identify hidden overvaluation or the stability of the company's market positions.

ZJYL Jin Medical International Ltd P/S Multiple (05/11/2024 - 11/17/2026)

Analytical breakdowns for Jin Medical International Ltd. (ZJYL)

- stock exchange capitalization data:
General company analysis:ZJYL Jin Medical International
Core merchandise of Jin Medical

The scale of operations at Jin Medical International (ZJYL) is determined by the sales volume of specialized equipment. By analyzing the company's P/S chart, an investor assesses the market value of the business relative to its actual cash flows from sales. This metric reveals asset overvaluation, particularly amid rising aluminum prices and trade tariff risks. The stability of this indicator confirms the business's resilience to supply chain volatility.

Competitors of Jin Medical International

Market Cap to Revenue Boston Scientific Corporation BSX|P/S Multiple EW (Edwards Lifesciences)|ResMed Corp (RMD) - Price to Sales|Insulet Corp - P/S Multiple|ZBH (zimmerbiomet.com) - Market Cap to Revenue Ratio|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (NuVasive) - P/S Multiple|TransMedics Corp (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion, Inc. AORT|P/S Multiple ENOV (enovis.com)|P/S Multiple Integra LifeSciences Corp IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (IRADIMED CORPORATION) - Market Cap to Revenue|Embecta Corp. - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Corp) - P/S Multiple|Price to Sales AxoGen Inc AXGN|Price-to-Revenue Ratio SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Price-to-Revenue Multiple|P/S Multiple BVS (bioventus.com)|P/S Multiple OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - P/S Multiple|Price-to-Revenue Coefficient Blade Air Mobility SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Ophthalmic)|Price-to-Revenue Ratio clearpointneuro.com|Market Cap to Revenue Stereotaxis, Inc. (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Revenue Ratio|NSPR: Market Cap to Revenue|Vivani Medical Inc - Market Cap to Sales Volume|XTNT (Xtant Medical Holdings) - Market Cap to Revenue|Market Cap to Revenue Ratio NMTC|Price-to-Revenue Ratio Modular Medical Inc|Price to Sales Myomo Inc MYO|Market Cap to Revenue COCH (Envoy Medical, Inc.)|Price-to-Revenue Ratio VVOS (vivoslife.com)|enVVeno Medical Corp. - Market Cap to Revenue|Market Cap to Sales Volume SINT (sintx.com)|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|autonomix.com (AMIX) - Price-to-Revenue Ratio|Price to Sales invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - P/S Multiple|Axonics Modulation Technologies (AXNX) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (Biolase, Inc.)|Dynatronics - Market Cap to Revenue Ratio|Paragon 28, Inc. - Market Cap to Revenue|Price-to-Revenue Coefficient INVO Bio (INVO)